Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Exp Hematol

Retrieve available abstracts of 119 articles:
HTML format

Single Articles

    June 2021
  1. KAEHLER M, Dworschak M, Rodin JP, Ruemenapp J, et al
    ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells.
    Exp Hematol. 2021 Jun 3. pii: S0301-472X(21)00199.
    PubMed     Abstract available

    May 2021
  2. GRANDITS AM, Wieser R
    Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.
    Exp Hematol. 2021 May 21. pii: S0301-472X(21)00195.
    PubMed     Abstract available

    March 2021
  3. MONDET J, Presti CL, Chevalier S, Bertrand A, et al
    Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles.
    Exp Hematol. 2021 Mar 6. pii: S0301-472X(21)00095.
    PubMed     Abstract available

    February 2021
  4. VILLAUME MT, Arrate MP, Ramsey HE, Sunthankar KI, et al
    The delta isoform of PI3K predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib.
    Exp Hematol. 2021 Feb 19. pii: S0301-472X(21)00089.
    PubMed     Abstract available

  5. SWART LE, Heidenreich O
    The RUNX1/RUNX1T1 network: translating insights into therapeutic options.
    Exp Hematol. 2021;94:1-10.
    PubMed     Abstract available

    January 2021
  6. WEI H, Liu X, Wang Y, Lin D, et al
    The Optimized Clinical Application of Minimal Residual Disease in Acute Myeloid Leukemia with RUNX1-RUNX1T1.
    Exp Hematol. 2021 Jan 29. pii: S0301-472X(21)00032.
    PubMed     Abstract available

  7. BATSIVARI A, Grey W, Bonnet PD
    Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in Acute Myeloid Leukemia.
    Exp Hematol. 2021 Jan 23. pii: S0301-472X(21)00026.
    PubMed     Abstract available

  8. RUSSKAMP NF, Myburgh R, Kiefer JD, Neri D, et al
    Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells.
    Exp Hematol. 2021 Jan 20. pii: S0301-472X(21)00004.
    PubMed     Abstract available

  9. MAKI H, Yoshimi A, Shimada T, Arai S, et al
    Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia.
    Exp Hematol. 2021 Jan 14. pii: S0301-472X(20)30666.
    PubMed     Abstract available

  10. BLANCO G, Puiggros A, Sherry B, Nonell L, et al
    CLL-like monoclonal B cell lymphocytosis displays an increased inflammatory signature that is reduced in early stage chronic lymphocytic leukemia.
    Exp Hematol. 2021 Jan 6. pii: S0301-472X(21)00001.
    PubMed     Abstract available

  11. AREDE L, Pina C
    Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development.
    Exp Hematol. 2021;93:25-37.
    PubMed     Abstract available

    November 2020
  12. CHIN PS, Assi SA, Ptasinska A, Imperato MR, et al
    RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia.
    Exp Hematol. 2020 Nov 2. pii: S0301-472X(20)30618.
    PubMed     Abstract available

    October 2020
  13. SYMEONIDOU V, Ottersbach K
    HOXA9/IRX1 expression pattern defines two sub-groups of infant MLL-AF4-driven Acute Lymphoblastic Leukemia.
    Exp Hematol. 2020 Oct 15. pii: S0301-472X(20)30593.
    PubMed     Abstract available

  14. FITCH B, Roy R, Geng H, Montecino-Rodriguez E, et al
    Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature.
    Exp Hematol. 2020;90:65-71.
    PubMed     Abstract available

    September 2020
  15. HENGEVELD PJ, Levin MD, Kolijn PM, Langerak AW, et al
    Reading the B cell receptor Immunome in Chronic Lymphocytic Leukemia: Revelations and Applications.
    Exp Hematol. 2020 Sep 22. pii: S0301-472X(20)30559.
    PubMed     Abstract available

  16. BOILA LD, Sengupta A
    Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
    Exp Hematol. 2020 Sep 17. pii: S0301-472X(20)30554.
    PubMed     Abstract available

  17. JACOBS S, Ausema A, Zwart E, Weersing E, et al
    Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes.
    Exp Hematol. 2020 Sep 15. pii: S0301-472X(20)30553.
    PubMed     Abstract available

  18. TANAKA Y, Mikami K, Adachi K, Fukushima T, et al
    Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells.
    Exp Hematol. 2020 Sep 7. pii: S0301-472X(20)30548.
    PubMed     Abstract available

  19. YOUNG K, Loberg MA, Eudy E, Schwartz LS, et al
    Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias.
    Exp Hematol. 2020;89:61-67.
    PubMed     Abstract available

  20. ZANETTI C, Krause DS
    "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
    Exp Hematol. 2020;89:13-25.
    PubMed     Abstract available

  21. KANIYATTU SM, Meenakshi A, Kumar MB, Kumar KR, et al
    Cytogenetic and cytokine profile in elderly patients with cytopenia.
    Exp Hematol. 2020;89:80-86.
    PubMed     Abstract available

    August 2020
  22. LIN H, Damen JE, Walasek MA, Szilvassy SJ, et al
    A Feeder-Free and Serum-Free In Vitro Assay for Measuring the Effect of Drugs on Acute and Chronic Myeloid Leukemia Stem/Progenitor Cells.
    Exp Hematol. 2020 Aug 13. pii: S0301-472X(20)30349.
    PubMed     Abstract available

  23. HOSNIJEH FS, van der Straten L, Kater AP, van Oers MHJ, et al
    Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study.
    Exp Hematol. 2020 Aug 8. pii: S0301-472X(20)30308.
    PubMed     Abstract available

    July 2020
  24. BOTTARDI S, Guieze R, Bourgoin V, Fotouhi-Ardakani N, et al
    MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells.
    Exp Hematol. 2020 Jul 16. pii: S0301-472X(20)30269.
    PubMed     Abstract available

  25. YAN B, Claxton D, Huang S, Qiu Y, et al
    AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy.
    Exp Hematol. 2020;87:13-19.
    PubMed     Abstract available

  26. DEUTSCH JL, Heath JL
    MLLT10 in benign and malignant hematopoiesis.
    Exp Hematol. 2020;87:1-12.
    PubMed     Abstract available

    June 2020
  27. HE X, Dou A, Feng S, Roman-Rivera A, et al
    Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro.
    Exp Hematol. 2020;86:21-27.
    PubMed     Abstract available

    May 2020
  28. SINHA R, Porcheri C, d'Altri T, Gonzalez J, et al
    Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Exp Hematol. 2020 May 10. pii: S0301-472X(20)30146.
    PubMed     Abstract available

  29. LENARD A, Xie HM, Pastuer T, Shank T, et al
    Epigenetic regulation of protein translation in KMT2A-rearranged AML.
    Exp Hematol. 2020;85:57-69.
    PubMed     Abstract available

    April 2020
  30. PAGLIARO S, Desterke C, Acloque H, Chomel JC, et al
    Exp Hematol. 2020 Apr 28. pii: S0301-472X(20)30142.
    PubMed     Abstract available

  31. RAZ O, Granot G, Pasmanik-Chor M, Raanani P, et al
    Profiling and Bioinformatics Analyses Reveal Chronic Lymphocytic Leukemia Cells Share a Unique Circular RNA Expression Pattern.
    Exp Hematol. 2020 Apr 10. pii: S0301-472X(20)30137.
    PubMed     Abstract available

    March 2020
  32. SWIERCZEK S, Prchal JT
    Clonal hematopoiesis in hematological disorders: Three different scenarios.
    Exp Hematol. 2020;83:57-65.
    PubMed     Abstract available

  33. COOK EK, Luo M, Rauh MJ
    Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity.
    Exp Hematol. 2020;83:85-94.
    PubMed     Abstract available

    February 2020
  34. KRONSTEIN-WIEDEMANN R, Klop O, Thiel J, Milanov P, et al
    K562 erythroleukemia line as a possible reticulocyte source to culture Plasmodium vivax and its surrogates.
    Exp Hematol. 2020;82:8-23.
    PubMed     Abstract available

    January 2020
  35. XUE S, Lam YM, He Z, Zheng Y, et al
    Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
    Exp Hematol. 2020 Jan 30. pii: S0301-472X(20)30026.
    PubMed     Abstract available

  36. LEE-SIX H, Kent DG
    Tracking hematopoietic stem cells and their progeny using whole-genome sequencing.
    Exp Hematol. 2020 Jan 30. pii: S0301-472X(20)30024.
    PubMed     Abstract available

  37. STRASZKOWSKI L, Jovic T, Castillo-Tandazo W, Ritchie DS, et al
    The effects of chemotherapy agents used to treat pediatric acute lymphoblastic leukemia patients on bone parameters and longitudinal growth of juvenile mice.
    Exp Hematol. 2020 Jan 29. pii: S0301-472X(20)30031.
    PubMed     Abstract available

  38. AKAHOSHI Y, Nakasone H, Kawamura K, Kusuda M, et al
    Detection of T315I using digital polymerase chain reaction in allogeneic transplant recipients with Ph-positive acute lymphoblastic anemia in the dasatinib era.
    Exp Hematol. 2020 Jan 11. pii: S0301-472X(20)30001.
    PubMed     Abstract available

    December 2019
  39. NISHIMURA T, Hsu I, Martinez-Krams DC, Nakauchi Y, et al
    Use of polyvinyl alcohol for chimeric antigen receptor T-cell expansion.
    Exp Hematol. 2019;80:16-20.
    PubMed     Abstract available

    September 2019
  40. ANTELOPE O, Vellore N, Pomicter AD, Patel AB, et al
    BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits pre-clinical activity in Philadelphia chromosome-positive leukemia.
    Exp Hematol. 2019 Sep 4. pii: S0301-472X(19)30950.
    PubMed     Abstract available

  41. LUIS TC, Wilkinson AC, Beerman I, Jaiswal S, et al
    Biological implications of clonal hematopoiesis.
    Exp Hematol. 2019;77:1-5.
    PubMed     Abstract available

    July 2019
  42. HONG CS, Danet-Desnoyers G, Shan X, Sharma P, et al
    Human acute myeloid leukemia blast-derived exosomes in patient derived xenograft mice mediate immune suppression.
    Exp Hematol. 2019 Jul 29. pii: S0301-472X(19)30918.
    PubMed     Abstract available

  43. JAFEK JL, Shakya A, Tai PY, Ibarra A, et al
    Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia.
    Exp Hematol. 2019 Jul 8. pii: S0301-472X(19)30855.

    June 2019
  44. VAIKARI VP, Yang J, Wu S, Alachkar H, et al
    CD97 is associated with poor overall survival in Acute Myeloid Leukemia.
    Exp Hematol. 2019 Jun 28. pii: S0301-472X(19)30802.
    PubMed     Abstract available

  45. AHN JS, Kim T, Kim YK, Cho YC, et al
    Remission clone in acute myeloid leukemia shows growth advantage after chemotherapy but is distinct from leukemic clone.
    Exp Hematol. 2019 Jun 11. pii: S0301-472X(19)30329.
    PubMed     Abstract available

    May 2019
  46. MILAN T, Canaj HV, Villeneuve C, Ghosh A, et al
    Pediatric Leukemia: moving towards more accurate models.
    Exp Hematol. 2019 May 30. pii: S0301-472X(19)30320.
    PubMed     Abstract available

  47. ANDERSON E, Rees B, Hull J, Heywood J, et al
    Intracellular cytarabine triphosphate in circulating blasts post-treatment predicts remission status in patients with acute myeloid leukemia.
    Exp Hematol. 2019 May 2. pii: S0301-472X(19)30191.
    PubMed     Abstract available

  48. PORTALE F, Beneforti L, Fallati A, Biondi A, et al
    Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia.
    Exp Hematol. 2019;73:7-12.
    PubMed     Abstract available

    April 2019
  49. BARBOSA K, Deshpande A, Chen BR, Ghosh A, et al
    Acute Myeloid Leukemia Driven by the CALM-AF10 Fusion Gene is Dependent on BMI1.
    Exp Hematol. 2019 Apr 22. pii: S0301-472X(19)30187.
    PubMed     Abstract available

  50. XU LS, Francis A, Turkistany S, Shukla D, et al
    ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B cell acute lymphoblastic leukemia.
    Exp Hematol. 2019 Apr 12. pii: S0301-472X(19)30134.
    PubMed     Abstract available

  51. MATTES K, Geugien M, Korthuis PM, Brouwers-Vos AZ, et al
    The transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
    Exp Hematol. 2019 Apr 12. pii: S0301-472X(19)30133.
    PubMed     Abstract available

    February 2019
  52. HERNANDEZ-SANCHEZ M, Rodriguez-Vicente AE, Gonzalez-Gascon Y Marin I, Quijada-Alamo M, et al
    DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia patients and chromosomal gains.
    Exp Hematol. 2019 Feb 23. pii: S0301-472X(19)30073.
    PubMed     Abstract available

  53. SHAPIRA S, Raanani P, Samara A, Nagler A, et al
    Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34(+)CD38(-) cells through iron chelation, induction of ROS, and inhibition of HIF1alpha expression.
    Exp Hematol. 2019;70:55-69.
    PubMed     Abstract available

    January 2019
  54. TURHAN AG, Foudi A, Hwang JW, Desterke C, et al
    Exp Hematol. 2019 Jan 16. pii: S0301-472X(19)30008.
    PubMed     Abstract available

  55. DANNENMANN B, Zahabi A, Mir P, Oswald B, et al
    Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34(+) cells preceding leukemic transformation.
    Exp Hematol. 2019 Jan 4. pii: S0301-472X(19)30004.
    PubMed     Abstract available

  56. LUCIANI GM, Xie L, Dilworth D, Tierens A, et al
    Characterization of inv(3) cell line OCI-AML-20 with stroma-dependent CD34 expression.
    Exp Hematol. 2019;69:27-36.
    PubMed     Abstract available

    December 2018
  57. GUILLAUME T, Dehame V, Chevallier P, Peterlin P, et al
    Targeting cell-bound MUC1 on myelomonocytic, monocytic leukemias and phenotypically defined leukemic stem cells with anti-SEA module antibodies.
    Exp Hematol. 2018 Dec 26. pii: S0301-472X(18)30987.
    PubMed     Abstract available

    November 2018
  58. SHANG J, Chen WM, Wang ZH, Wei TN, et al
    CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis.
    Exp Hematol. 2018 Nov 2. pii: S0301-472X(18)30873.
    PubMed     Abstract available

  59. BARVE A, Casson L, Krem M, Wunderlich M, et al
    Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
    Exp Hematol. 2018;67:18-31.
    PubMed     Abstract available

  60. VALDEZ BC, Tang X, Li Y, Murray D, et al
    Epigenetic modification enhances the cytotoxicity of busulfan and4-hydroperoxycyclophosphamide in AML cells.
    Exp Hematol. 2018;67:49-59.
    PubMed     Abstract available

    October 2018
  61. CHEN Y, Jones KL, Anastassiadis K, Kranz A, et al
    Distinct Pathways Affected by Menin versus MLL1/MLL2 in MLL-rearranged Acute Myeloid Leukemia.
    Exp Hematol. 2018 Oct 10. pii: S0301-472X(18)30851.
    PubMed     Abstract available

  62. GHORASHIAN S, Amrolia P, Veys P
    Open access? Widening access to chimeric antigen receptor (CAR) therapy for ALL.
    Exp Hematol. 2018;66:5-16.
    PubMed     Abstract available

  63. SALOME M, Hopcroft L, Keeshan K
    Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
    Exp Hematol. 2018;66:63-78.
    PubMed     Abstract available

    September 2018
  64. SENFT D, Jeremias I
    A rare subgroup of leukemia stem cells harbours relapse-inducing potential in acute lymphoblastic leukemia.
    Exp Hematol. 2018 Sep 24. pii: S0301-472X(18)30807.
    PubMed     Abstract available

  65. LI X, Xu L, Shen X, Cai J, et al
    Up-regulated miR-146a expression induced by G-CSF enhanced low dosage chemotherapy response in aged acute myeloid leukemia patients.
    Exp Hematol. 2018 Sep 9. pii: S0301-472X(18)30799.
    PubMed     Abstract available

  66. PAN B, Yang J, Wang X, Xu K, et al
    miR-217 sensitizes chronic myelogenous leukemia cells to tyrosine kinase inhibitors by targeting pro-oncogenic anterior gradient 2.
    Exp Hematol. 2018 Sep 5. pii: S0301-472X(18)30798.
    PubMed     Abstract available

  67. HEIBLIG M, Rea D, Chretien ML, Charbonnier A, et al
    Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: The PEARL observational study.
    Exp Hematol. 2018 Sep 5. pii: S0301-472X(18)30795.
    PubMed     Abstract available

    August 2018
  68. GAO S, Zhou B, Li H, Huang X, et al
    Long non-coding RNA HOTAIR promotes the self-renewal of leukemia stem cell through epigenetic silencing of p15.
    Exp Hematol. 2018 Aug 30. pii: S0301-472X(18)30752.
    PubMed     Abstract available

  69. BORGES CS, Ferreira AF, Almeida VH, Gomes FG, et al
    Exp Hematol. 2018 Aug 1. pii: S0301-472X(18)30746.
    PubMed     Abstract available

    July 2018
  70. KOTB A, Fakih RE, Hanbali A, Hawsawi Y, et al
    Philadelphia-Like Acute Lymphoblastic Leukemia: Diagnostic dilemma and management perspectives.
    Exp Hematol. 2018 Jul 31. pii: S0301-472X(18)30743.
    PubMed     Abstract available

  71. AZOULAY D, Herishanu Y, Shapiro M, Brandshaft Y, et al
    Elevated serum BDNF levels are associated with favorable outcome in CLL patients: Possible link to CXCR4 downregulation.
    Exp Hematol. 2018;63:17-21.
    PubMed     Abstract available

  72. WESTON VJ, Wei W, Stankovic T, Kearns P, et al
    Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.
    Exp Hematol. 2018;63:52-63.
    PubMed     Abstract available

    June 2018
  73. NARAYAN N, Bracken CP, Ekert PG
    MicroRNA-155 expression and function in AML: An evolving paradigm.
    Exp Hematol. 2018;62:1-6.
    PubMed     Abstract available

    May 2018
  74. NICOLINI FE, Alcazer V, Cony-Makhoul P, Heiblig M, et al
    Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on imatinib first-line.
    Exp Hematol. 2018 May 22. pii: S0301-472X(18)30259.
    PubMed     Abstract available

  75. SHI X, Kitano A, Jiang Y, Luu V, et al
    Clonal expansion and myeloid leukemia progression modeled by multiplex gene editing of murine hematopoietic progenitor cells.
    Exp Hematol. 2018 May 8. pii: S0301-472X(18)30256.
    PubMed     Abstract available

  76. JENKINS CE, Gusscott S, Wong RJ, Shevchuk OO, et al
    RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes.
    Exp Hematol. 2018 May 4. pii: S0301-472X(18)30217.
    PubMed     Abstract available

  77. DESTERKE C, Voldoire M, Bonnet ML, Sorel N, et al
    Experimental and integrative analyses identify an ETS1 network downstream BCR-ABL in chronic myeloid leukemia (CML).
    Exp Hematol. 2018 May 4. pii: S0301-472X(18)30216.
    PubMed     Abstract available

  78. MIHALYOVA J, Jelinek T, Growkova K, Hrdinka M, et al
    Venetoclax: A new wave in hematooncology.
    Exp Hematol. 2018;61:10-25.
    PubMed     Abstract available

    April 2018
  79. THURGOOD LA, Lower KM, Macardle C, Kuss BJ, et al
    Aberrant detection of phenotypic markers in chronic lymphocytic leukemia (CLL) lymphocytes following cryopreservation.
    Exp Hematol. 2018 Apr 26. pii: S0301-472X(18)30172.
    PubMed     Abstract available

  80. TIJCHON E, van Emst L, Yuniati L, van Ingen Schenau D, et al
    Tumor suppressor BTG1 limits activation of BCL6 expression downstream of ETV6-RUNX1.
    Exp Hematol. 2018;60:57-62.
    PubMed     Abstract available

    March 2018
  81. NEWCOMBE AA, Gibson BES, Keeshan K
    Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Exp Hematol. 2018 Mar 30. pii: S0301-472X(18)30166.
    PubMed     Abstract available

  82. ORTI G, Sanz J, Garcia-Cadenas I, Sanchez-Ortega I, et al
    Analysis of relapse post transplant in acute leukemia, a comparative on second allogeneic hematopoietic cell transplant and donor lymphocyte infusions.
    Exp Hematol. 2018 Mar 8. pii: S0301-472X(18)30120.
    PubMed     Abstract available

    February 2018
  83. ZYLBERSZTEJN F, Flores-Violante M, Voeltzel T, Nicolini FE, et al
    The BMP pathway: a unique tool to decode origin and progression of leukemia.
    Exp Hematol. 2018 Feb 22. pii: S0301-472X(18)30077.
    PubMed     Abstract available

  84. LI H, Xing C, Zhou B, Ye H, et al
    A regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemia.
    Exp Hematol. 2018 Feb 13. pii: S0301-472X(18)30041.
    PubMed     Abstract available

  85. DUSSIAU C, Fontenay M
    Mechanisms underlying the heterogeneity of myelodysplastic syndromes.
    Exp Hematol. 2018;58:17-26.
    PubMed     Abstract available

    January 2018
  86. GONG Y, Zhao M, Yang W, Gao A, et al
    Megakaryocyte-derived excessive TGFbeta1 inhibits proliferation of normal hematopoietic stem cells in acute myeloid leukemia.
    Exp Hematol. 2018 Jan 4. pii: S0301-472X(17)30909.
    PubMed     Abstract available

    December 2017
  87. GRIESSINGER E, Vargaftig J, Horswell S, Taussig DC, et al
    Acute myeloid leukemia xenograft success prediction: saving time.
    Exp Hematol. 2017 Dec 15. pii: S0301-472X(17)30900.
    PubMed     Abstract available

    November 2017
  88. CASTAGNA L, Devillier R, Vey N, Blaise D, et al
    T cell replete-haploidentical transplantation in acute myeloid leukemia.
    Exp Hematol. 2017 Nov 16. pii: S0301-472X(17)30861.
    PubMed     Abstract available

  89. CULL AH, Snetsinger B, Buckstein R, Wells RA, et al
    Tet2 restrains inflammatory gene expression in macrophages.
    Exp Hematol. 2017;55:56-70.
    PubMed     Abstract available

    October 2017
  90. BOILA LD, Chatterjee SS, Banerjee D, Sengupta A, et al
    KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.
    Exp Hematol. 2017 Oct 27. pii: S0301-472X(17)30824.
    PubMed     Abstract available

  91. WILLMANN M, Sadovnik I, Eisenwort G, Entner M, et al
    Evaluation of cooperative anti-leukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia.
    Exp Hematol. 2017 Oct 12. pii: S0301-472X(17)30816.
    PubMed     Abstract available

  92. HASSAN C, Afshinnekoo E, Li S, Wu S, et al
    Genetic and epigenetic heterogeneity and the impact on cancer relapse.
    Exp Hematol. 2017;54:26-30.
    PubMed     Abstract available

    September 2017
  93. GREGORY MA, Nemkov T, Reisz JA, Zaberezhnyy V, et al
    Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia.
    Exp Hematol. 2017 Sep 22. pii: S0301-472X(17)30776.
    PubMed     Abstract available

  94. LAGACE K, Barabe F, Hebert J, Cellot S, et al
    Identification of novel biomarkers for MLL translocated acute myeloid leukemia.
    Exp Hematol. 2017 Sep 11. pii: S0301-472X(17)30758.
    PubMed     Abstract available

  95. CHAN LN, Muschen M
    B-cell identity as a metabolic barrier against malignant transformation.
    Exp Hematol. 2017;53:1-6.
    PubMed     Abstract available

    August 2017
  96. HEROLD N, Rudd SG, Sanjiv K, Kutzner J, et al
    With me or against me: Tumor suppressor and drug resistance activities of SAMHD1.
    Exp Hematol. 2017;52:32-39.
    PubMed     Abstract available

  97. KIM YM, Gang EJ, Kahn M
    CBP/Catenin antagonists: Targeting LSCs' Achilles heel.
    Exp Hematol. 2017;52:1-11.
    PubMed     Abstract available

    July 2017
  98. ZHANG J, Griffith M, Miller CA, Griffith OL, et al
    Comprehensive discovery of non-coding RNAs in acute myeloid leukemia cell transcriptomes.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30701.
    PubMed     Abstract available

  99. YALCIN A, Kovarbasic M, Wehrle J, Claus R, et al
    The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30702.
    PubMed     Abstract available

  100. MARTINO B, Mammi C, Labate C, Rodi S, et al
    Genetic risk of prediabetes and diabetes development in chronic myeloid leukemia patients treated with nilotinib.
    Exp Hematol. 2017 Jul 28. pii: S0301-472X(17)30663.
    PubMed     Abstract available

  101. CARRETTA M, de Boer B, Jaques J, Antonelli A, et al
    Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models.
    Exp Hematol. 2017;51:36-46.
    PubMed     Abstract available

  102. LEPRETRE S, Graux C, Touzart A, Macintyre E, et al
    Adult T-type lymphoblastic lymphoma: Treatment advances and prognostic indicators.
    Exp Hematol. 2017;51:7-16.
    PubMed     Abstract available

    June 2017
  103. LAING AA, Harrison CJ, Gibson BES, Keeshan K, et al
    Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
    Exp Hematol. 2017 Jun 28. pii: S0301-472X(17)30237.
    PubMed     Abstract available

  104. SANDA T, Leong WZ
    TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2017 Jun 23. pii: S0301-472X(17)30231.
    PubMed     Abstract available

  105. SLOMA I, Mitjavila-Garcia M, Feraud O, Griscelli F, et al
    Whole genome analysis reveals unexpected dynamics of mutant subclone development in a patient with JAK2-V617F-positive chronic myeloid leukemia.
    Exp Hematol. 2017 Jun 7. pii: S0301-472X(17)30192.
    PubMed     Abstract available

  106. PORTER SN, Magee JA
    PRKCH regulates hematopoietic stem cell function and predicts poor prognosis in acute myeloid leukemia.
    Exp Hematol. 2017 Jun 5. pii: S0301-472X(17)30190.
    PubMed     Abstract available

    May 2017
  107. OMORI I, Yamaguchi H, Miyake K, Miyake N, et al
    D816V mutation in the KIT gene activation loop has a greater cell proliferative and anti-apoptotic ability than N822K mutation in core binding factor-acute myeloid leukemia.
    Exp Hematol. 2017 May 12. pii: S0301-472X(17)30146.
    PubMed     Abstract available

  108. SHEN Y, Chen TJ, Lacorazza HD
    Novel tumor suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemia.
    Exp Hematol. 2017 May 4. pii: S0301-472X(17)30141.
    PubMed     Abstract available

    April 2017
  109. SADOVNIK I, Herrmann H, Eisenwort G, Blatt K, et al
    Expression of CD25 on Leukemic Stem Cells in BCR-ABL1+ CML: Potential Diagnostic Value and Functional Implications.
    Exp Hematol. 2017 Apr 27. pii: S0301-472X(17)30135.
    PubMed     Abstract available

  110. VAN GILS N, Verhagen HJMP, Smit L
    Reprogramming acute myeloid leukemia into sensitivity for retinoic acid-driven differentiation.
    Exp Hematol. 2017 Apr 26. pii: S0301-472X(17)30139.
    PubMed     Abstract available

  111. SASAKI T, Rivera-Mulia JC, Vera D, Zimmerman J, et al
    Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia.
    Exp Hematol. 2017 Apr 19. pii: S0301-472X(17)30136.
    PubMed     Abstract available

  112. CHOI EJ, Kim MS, Yoo NJ, Lee SH, et al
    Mutational analysis of hypermutation-related POLE gene in acute leukemias and lymphomas.
    Exp Hematol. 2017;48:39-40.

    March 2017
  113. GHOSH J, Kapur R
    Role of mTORC1-S6K1 signaling pathway in regulation of hematopoietic stem cell and acute myeloid leukemia.
    Exp Hematol. 2017 Mar 22. pii: S0301-472X(17)30063.
    PubMed     Abstract available

  114. CLARKE CJ, Holyoake TL
    Preclinical approaches in chronic myeloid leukemia: from cells to systems.
    Exp Hematol. 2017;47:13-23.
    PubMed     Abstract available

  115. UTTARKAR S, Frampton J, Klempnauer KH
    Targeting the transcription factor Myb by small-molecule inhibitors.
    Exp Hematol. 2017;47:31-35.
    PubMed     Abstract available

  116. BOGEN A, Buske C, Hiddemann W, Bohlander SK, et al
    Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
    Exp Hematol. 2017;47:54-63.
    PubMed     Abstract available

    February 2017
    Transcriptional activation by MLL fusion proteins in leukemogenesis.
    Exp Hematol. 2017;46:21-30.
    PubMed     Abstract available

    January 2017
  118. AN X, Liu J, Wang N, Wang D, et al
    AC220 and AraC cause differential inhibitory dynamics in patient-derived M5-AML with FLT3-ITD and, thus, ultimately distinct therapeutic outcomes.
    Exp Hematol. 2017;45:36-44.
    PubMed     Abstract available

    May 2016
  119. TESTA U, Labbaye C, Castelli G, Pelosi E, et al
    Oxidative Stress and Hypoxia in Normal and Leukemic Stem Cells.
    Exp Hematol. 2016 May 11. pii: S0301-472X(16)30116.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.